Australia Banking Times
SEE OTHER BRANDS

Your best source on finance and banking news from Australia

Australia Banking Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Australia Banking Times.

Press releases published on April 23, 2025

Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2025

Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2025

Year-over-year revenue grows 8%, operating profit up 14%, non-GAAP operating profit up 13% Operating cash flow of $579 million Note: A webcast of Resmed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, …

XRP News: XenDex Announces $XDX Token Sale As SEC Drops Ripple (XRP) Lawsuit

XRP News: XenDex Announces $XDX Token Sale As SEC Drops Ripple (XRP) Lawsuit

SYDNEY, Australia, April 23, 2025 (GLOBE NEWSWIRE) -- XenDex is thrilled to announce the first AI-powered all-in-one decentralized exchange (DEX) built on XRP, combining non-custodial lending and borrowing, AI copy trading, and DAO governance in a single …

XRP News: XenDex Presale Begins As XRP ETF Builds Momentum

XRP News: XenDex Presale Begins As XRP ETF Builds Momentum

SYDNEY, April 23, 2025 (GLOBE NEWSWIRE) -- XenDex is thrilled to announce the first AI-powered all-in-one decentralized exchange (DEX) built on XRP, combining non-custodial lending and borrowing, AI copy trading, and DAO governance in a single user-centric …

FXBO and FiveComply Join Forces to Elevate Broker Solutions

FXBO and FiveComply Join Forces to Elevate Broker Solutions

CYPRUS, April 23, 2025 /⁨Business News⁩/ -- FXBO and FiveComply have announced a new strategic partnership designed to deliver superior support to brokers operating within today’s complex financial services landscape. By uniting FXBO’s advanced back-office …

Recce Pharmaceuticals Receives Approval for Additional Phase II Trial of RECCE® 327 Topical Gel for Diabetic Foot Infections

Recce Pharmaceuticals Receives Approval for Additional Phase II Trial of RECCE® 327 Topical Gel for Diabetic Foot Infections

Human Research Ethics Committee (HREC) approval received to allow up to 20 additional patients access to RECCE® 327 Topical Gel (R327G) treatment under existing open-label study protocol Program enables access to R327G for diabetic foot infections (DFI), …

Update on Transaction Regulatory Approvals

Update on Transaction Regulatory Approvals

BRISBANE, Australia, April 23, 2025 (GLOBE NEWSWIRE) -- Sayona Mining Limited (“Sayona” or “Company”) (ASX:SYA; OTCQB:SYAXF) provides an update on the proposed transaction with Piedmont Lithium Inc. (“Piedmont Lithium”) (NASDAQ:PLL, ASX:PLL) (see …

Sayona Mining Limited (SYA.AX) March 2025 Quarterly Report Advisory

Sayona Mining Limited (SYA.AX) March 2025 Quarterly Report Advisory

Sayona Mining Limited Brisbane, Australia, April 23, 2025 - (ABN Newswire) - North American lithium producer Sayona Mining Limited (ASX:SYA) (HAM:DML) (OTCMKTS:SYAXF) advises that the Company's March 2025 Quarterly Activities Report is scheduled for …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service